nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—Alvimopan—Indinavir—acquired immunodeficiency syndrome	0.289	1	CrCrCtD
Ketoprofen—ALB—acquired immunodeficiency syndrome	0.142	1	CbGaD
Ketoprofen—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0279	0.0712	CbGbCtD
Ketoprofen—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.0274	0.0699	CbGbCtD
Ketoprofen—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0261	0.0666	CbGbCtD
Ketoprofen—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0255	0.0651	CbGbCtD
Ketoprofen—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0218	0.0555	CbGbCtD
Ketoprofen—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0212	0.0539	CbGbCtD
Ketoprofen—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0211	0.0539	CbGbCtD
Ketoprofen—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0198	0.0504	CbGbCtD
Ketoprofen—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0191	0.0487	CbGbCtD
Ketoprofen—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0191	0.0487	CbGbCtD
Ketoprofen—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.016	0.0407	CbGbCtD
Ketoprofen—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0111	0.0283	CbGbCtD
Ketoprofen—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0101	0.0257	CbGbCtD
Ketoprofen—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0101	0.0257	CbGbCtD
Ketoprofen—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00987	0.0252	CbGbCtD
Ketoprofen—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00947	0.0241	CbGbCtD
Ketoprofen—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0086	0.0219	CbGbCtD
Ketoprofen—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00826	0.0211	CbGbCtD
Ketoprofen—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00777	0.0198	CbGbCtD
Ketoprofen—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00777	0.0198	CbGbCtD
Ketoprofen—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00763	0.0195	CbGbCtD
Ketoprofen—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00763	0.0195	CbGbCtD
Ketoprofen—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00732	0.0186	CbGbCtD
Ketoprofen—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00702	0.0179	CbGbCtD
Ketoprofen—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00702	0.0179	CbGbCtD
Ketoprofen—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00606	0.0155	CbGbCtD
Ketoprofen—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00588	0.015	CbGbCtD
Ketoprofen—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00532	0.0136	CbGbCtD
Ketoprofen—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00532	0.0136	CbGbCtD
Ketoprofen—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0051	0.013	CbGbCtD
Ketoprofen—CXCR1—blood—acquired immunodeficiency syndrome	0.0018	0.0719	CbGeAlD
Ketoprofen—CXCR1—bone marrow—acquired immunodeficiency syndrome	0.00174	0.0696	CbGeAlD
Ketoprofen—CXCR1—lung—acquired immunodeficiency syndrome	0.00158	0.063	CbGeAlD
Ketoprofen—CXCR1—lymph node—acquired immunodeficiency syndrome	0.00108	0.0431	CbGeAlD
Ketoprofen—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.00082	0.0328	CbGeAlD
Ketoprofen—CXCL8—blood—acquired immunodeficiency syndrome	0.000638	0.0255	CbGeAlD
Ketoprofen—CXCL8—bone marrow—acquired immunodeficiency syndrome	0.000617	0.0247	CbGeAlD
Ketoprofen—CXCL8—spinal cord—acquired immunodeficiency syndrome	0.000615	0.0246	CbGeAlD
Ketoprofen—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000596	0.0238	CbGeAlD
Ketoprofen—CXCL8—vagina—acquired immunodeficiency syndrome	0.000591	0.0236	CbGeAlD
Ketoprofen—CXCL8—lung—acquired immunodeficiency syndrome	0.000559	0.0224	CbGeAlD
Ketoprofen—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.000555	0.0222	CbGeAlD
Ketoprofen—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000544	0.0217	CbGeAlD
Ketoprofen—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000541	0.0217	CbGeAlD
Ketoprofen—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000529	0.0212	CbGeAlD
Ketoprofen—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00052	0.0208	CbGeAlD
Ketoprofen—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000483	0.0193	CbGeAlD
Ketoprofen—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000462	0.0185	CbGeAlD
Ketoprofen—CXCL8—brain—acquired immunodeficiency syndrome	0.000396	0.0158	CbGeAlD
Ketoprofen—CXCL8—lymph node—acquired immunodeficiency syndrome	0.000382	0.0153	CbGeAlD
Ketoprofen—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000328	0.0131	CbGeAlD
Ketoprofen—SLC22A7—brain—acquired immunodeficiency syndrome	0.00032	0.0128	CbGeAlD
Ketoprofen—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000315	0.0126	CbGeAlD
Ketoprofen—SLC22A6—brain—acquired immunodeficiency syndrome	0.000309	0.0124	CbGeAlD
Ketoprofen—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000301	0.012	CbGeAlD
Ketoprofen—ABCC4—blood—acquired immunodeficiency syndrome	0.000301	0.012	CbGeAlD
Ketoprofen—SLC22A8—blood—acquired immunodeficiency syndrome	0.000298	0.0119	CbGeAlD
Ketoprofen—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000291	0.0116	CbGeAlD
Ketoprofen—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000274	0.0109	CbGeAlD
Ketoprofen—ABCC4—lung—acquired immunodeficiency syndrome	0.000263	0.0105	CbGeAlD
Ketoprofen—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000254	0.0101	CbGeAlD
Ketoprofen—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000244	0.00976	CbGeAlD
Ketoprofen—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000244	0.00976	CbGeAlD
Ketoprofen—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000242	0.00968	CbGeAlD
Ketoprofen—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000235	0.00939	CbGeAlD
Ketoprofen—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000233	0.00932	CbGeAlD
Ketoprofen—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000232	0.00928	CbGeAlD
Ketoprofen—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000222	0.00887	CbGeAlD
Ketoprofen—CYP2C8—blood—acquired immunodeficiency syndrome	0.000218	0.00872	CbGeAlD
Ketoprofen—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000203	0.00814	CbGeAlD
Ketoprofen—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000202	0.00809	CbGeAlD
Ketoprofen—Magnesium salicylate—ALB—acquired immunodeficiency syndrome	0.000198	0.254	CrCbGaD
Ketoprofen—CYP2C9—blood—acquired immunodeficiency syndrome	0.000194	0.00775	CbGeAlD
Ketoprofen—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000194	0.00775	CbGeAlD
Ketoprofen—ALB—brain—acquired immunodeficiency syndrome	0.000193	0.0077	CbGeAlD
Ketoprofen—ABCC4—brain—acquired immunodeficiency syndrome	0.000186	0.00746	CbGeAlD
Ketoprofen—ALB—lymph node—acquired immunodeficiency syndrome	0.000186	0.00744	CbGeAlD
Ketoprofen—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000186	0.00743	CbGeAlD
Ketoprofen—SLC22A8—brain—acquired immunodeficiency syndrome	0.000185	0.0074	CbGeAlD
Ketoprofen—ABCC4—lymph node—acquired immunodeficiency syndrome	0.00018	0.00721	CbGeAlD
Ketoprofen—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00018	0.00719	CbGeAlD
Ketoprofen—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000178	0.0071	CbGeAlD
Ketoprofen—PTGS1—blood—acquired immunodeficiency syndrome	0.000177	0.00708	CbGeAlD
Ketoprofen—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00017	0.00682	CbGeAlD
Ketoprofen—PTGS2—blood—acquired immunodeficiency syndrome	0.000169	0.00676	CbGeAlD
Ketoprofen—PTGS1—vagina—acquired immunodeficiency syndrome	0.000164	0.00656	CbGeAlD
Ketoprofen—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000164	0.00654	CbGeAlD
Ketoprofen—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000163	0.00652	CbGeAlD
Ketoprofen—CXCL8—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000161	0.00394	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000161	0.00393	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000161	0.00393	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000161	0.00393	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.00016	0.0039	CbGpPWpGaD
Ketoprofen—CXCL8—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000159	0.00388	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.000159	0.00388	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000157	0.00385	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.000157	0.00384	CbGpPWpGaD
Ketoprofen—PTGS2—vagina—acquired immunodeficiency syndrome	0.000157	0.00627	CbGeAlD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.000156	0.00382	CbGpPWpGaD
Ketoprofen—PTGS1—lung—acquired immunodeficiency syndrome	0.000155	0.0062	CbGeAlD
Ketoprofen—CXCR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000154	0.00376	CbGpPWpGaD
Ketoprofen—PTGS2—lung—acquired immunodeficiency syndrome	0.000148	0.00593	CbGeAlD
Ketoprofen—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000145	0.00354	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000144	0.00352	CbGpPWpGaD
Ketoprofen—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000144	0.00574	CbGeAlD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.00014	0.00343	CbGpPWpGaD
Ketoprofen—Fenoprofen—ALB—acquired immunodeficiency syndrome	0.000139	0.178	CrCbGaD
Ketoprofen—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000139	0.00339	CbGpPWpGaD
Ketoprofen—CXCR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000139	0.00339	CbGpPWpGaD
Ketoprofen—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000138	0.00553	CbGeAlD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000138	0.00338	CbGpPWpGaD
Ketoprofen—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000137	0.00549	CbGeAlD
Ketoprofen—CYP2C8—brain—acquired immunodeficiency syndrome	0.000135	0.00541	CbGeAlD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000135	0.00331	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000133	0.00325	CbGpPWpGaD
Ketoprofen—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000132	0.00529	CbGeAlD
Ketoprofen—CXCR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00013	0.00318	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000129	0.00314	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000127	0.00311	CbGpPWpGaD
Ketoprofen—Naproxen—ALB—acquired immunodeficiency syndrome	0.000127	0.162	CrCbGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000125	0.00305	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000125	0.00305	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000123	0.003	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000122	0.00299	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000122	0.00299	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000122	0.00299	CbGpPWpGaD
Ketoprofen—Phenprocoumon—ALB—acquired immunodeficiency syndrome	0.00012	0.154	CrCbGaD
Ketoprofen—CXCR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00012	0.00292	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000117	0.00285	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000117	0.00285	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000115	0.00281	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00011	0.00269	CbGpPWpGaD
Ketoprofen—PTGS1—brain—acquired immunodeficiency syndrome	0.00011	0.00439	CbGeAlD
Ketoprofen—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000109	0.00266	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000108	0.00264	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000108	0.00264	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000108	0.00264	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000107	0.00262	CbGpPWpGaD
Ketoprofen—Warfarin—ALB—acquired immunodeficiency syndrome	0.000107	0.136	CrCbGaD
Ketoprofen—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000106	0.00424	CbGeAlD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000106	0.00258	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000105	0.00257	CbGpPWpGaD
Ketoprofen—PTGS2—brain—acquired immunodeficiency syndrome	0.000105	0.0042	CbGeAlD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000104	0.00255	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000103	0.00253	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000102	0.00248	CbGpPWpGaD
Ketoprofen—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000101	0.00405	CbGeAlD
Ketoprofen—CXCL8—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	9.72e-05	0.00238	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	9.7e-05	0.00237	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	9.6e-05	0.00235	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	9.52e-05	0.00233	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	9.51e-05	0.00233	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	9.5e-05	0.00232	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	9.44e-05	0.00231	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	9.32e-05	0.00228	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.31e-05	0.00228	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	9.12e-05	0.00223	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	9.12e-05	0.00223	CbGpPWpGaD
Ketoprofen—Flurbiprofen—ALB—acquired immunodeficiency syndrome	9.09e-05	0.116	CrCbGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	9.07e-05	0.00222	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	8.91e-05	0.00218	CbGpPWpGaD
Ketoprofen—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	8.76e-05	0.00214	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL2—acquired immunodeficiency syndrome	8.64e-05	0.00211	CbGpPWpGaD
Ketoprofen—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	8.62e-05	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	8.53e-05	0.00209	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	8.44e-05	0.00206	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.39e-05	0.00205	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	8.39e-05	0.00205	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	8.35e-05	0.00204	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—ALB—acquired immunodeficiency syndrome	8.26e-05	0.00202	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	8.23e-05	0.00201	CbGpPWpGaD
Ketoprofen—Vomiting—Didanosine—acquired immunodeficiency syndrome	8.2e-05	0.000746	CcSEcCtD
Ketoprofen—Palpitations—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000746	CcSEcCtD
Ketoprofen—Insomnia—Indinavir—acquired immunodeficiency syndrome	8.19e-05	0.000745	CcSEcCtD
Ketoprofen—Oedema—Delavirdine—acquired immunodeficiency syndrome	8.19e-05	0.000745	CcSEcCtD
Ketoprofen—Anorexia—Efavirenz—acquired immunodeficiency syndrome	8.16e-05	0.000742	CcSEcCtD
Ketoprofen—Rash—Didanosine—acquired immunodeficiency syndrome	8.14e-05	0.00074	CcSEcCtD
Ketoprofen—Infection—Delavirdine—acquired immunodeficiency syndrome	8.13e-05	0.00074	CcSEcCtD
Ketoprofen—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	8.13e-05	0.00074	CcSEcCtD
Ketoprofen—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	8.13e-05	0.00074	CcSEcCtD
Ketoprofen—Dermatitis—Didanosine—acquired immunodeficiency syndrome	8.13e-05	0.00074	CcSEcCtD
Ketoprofen—Headache—Didanosine—acquired immunodeficiency syndrome	8.08e-05	0.000735	CcSEcCtD
Ketoprofen—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	8.07e-05	0.000735	CcSEcCtD
Ketoprofen—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	8.06e-05	0.000734	CcSEcCtD
Ketoprofen—Shock—Delavirdine—acquired immunodeficiency syndrome	8.05e-05	0.000733	CcSEcCtD
Ketoprofen—Malaise—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000733	CcSEcCtD
Ketoprofen—Somnolence—Indinavir—acquired immunodeficiency syndrome	8.05e-05	0.000732	CcSEcCtD
Ketoprofen—Asthenia—Stavudine—acquired immunodeficiency syndrome	8.04e-05	0.000731	CcSEcCtD
Ketoprofen—Convulsion—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000731	CcSEcCtD
Ketoprofen—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	8.02e-05	0.00073	CcSEcCtD
Ketoprofen—Vertigo—Saquinavir—acquired immunodeficiency syndrome	8.02e-05	0.00073	CcSEcCtD
Ketoprofen—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	8.02e-05	0.000729	CcSEcCtD
Ketoprofen—Hypertension—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000729	CcSEcCtD
Ketoprofen—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	7.99e-05	0.000727	CcSEcCtD
Ketoprofen—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	7.97e-05	0.000725	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	7.96e-05	0.000724	CcSEcCtD
Ketoprofen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	7.95e-05	0.000723	CcSEcCtD
Ketoprofen—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	7.94e-05	0.000722	CcSEcCtD
Ketoprofen—Pruritus—Stavudine—acquired immunodeficiency syndrome	7.93e-05	0.000721	CcSEcCtD
Ketoprofen—Asthenia—Abacavir—acquired immunodeficiency syndrome	7.92e-05	0.00072	CcSEcCtD
Ketoprofen—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	7.91e-05	0.00072	CcSEcCtD
Ketoprofen—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	7.9e-05	0.000719	CcSEcCtD
Ketoprofen—Myalgia—Ritonavir—acquired immunodeficiency syndrome	7.9e-05	0.000718	CcSEcCtD
Ketoprofen—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.87e-05	0.000716	CcSEcCtD
Ketoprofen—Anaemia—Lamivudine—acquired immunodeficiency syndrome	7.87e-05	0.000716	CcSEcCtD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	7.87e-05	0.00192	CbGpPWpGaD
Ketoprofen—Anxiety—Ritonavir—acquired immunodeficiency syndrome	7.87e-05	0.000716	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.82e-05	0.000711	CcSEcCtD
Ketoprofen—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.81e-05	0.00071	CcSEcCtD
Ketoprofen—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.81e-05	0.00071	CcSEcCtD
Ketoprofen—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.8e-05	0.00071	CcSEcCtD
Ketoprofen—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.8e-05	0.00071	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.8e-05	0.000709	CcSEcCtD
Ketoprofen—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.78e-05	0.000708	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.77e-05	0.0019	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	7.74e-05	0.00189	CbGpPWpGaD
Ketoprofen—Constipation—Indinavir—acquired immunodeficiency syndrome	7.74e-05	0.000705	CcSEcCtD
Ketoprofen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.74e-05	0.000704	CcSEcCtD
Ketoprofen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.74e-05	0.000704	CcSEcCtD
Ketoprofen—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000704	CcSEcCtD
Ketoprofen—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	7.72e-05	0.000703	CcSEcCtD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	7.71e-05	0.00189	CbGpPWpGaD
Ketoprofen—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000701	CcSEcCtD
Ketoprofen—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.7e-05	0.0007	CcSEcCtD
Ketoprofen—CXCL8—TSLP Signaling Pathway—IL6—acquired immunodeficiency syndrome	7.69e-05	0.00188	CbGpPWpGaD
Ketoprofen—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.69e-05	0.0007	CcSEcCtD
Ketoprofen—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.68e-05	0.000699	CcSEcCtD
Ketoprofen—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000699	CcSEcCtD
Ketoprofen—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.67e-05	0.000697	CcSEcCtD
Ketoprofen—Nausea—Didanosine—acquired immunodeficiency syndrome	7.66e-05	0.000697	CcSEcCtD
Ketoprofen—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.65e-05	0.000696	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	7.65e-05	0.00187	CbGpPWpGaD
Ketoprofen—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.63e-05	0.000694	CcSEcCtD
Ketoprofen—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.63e-05	0.000694	CcSEcCtD
Ketoprofen—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.61e-05	0.000692	CcSEcCtD
Ketoprofen—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.6e-05	0.000692	CcSEcCtD
Ketoprofen—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.57e-05	0.000689	CcSEcCtD
Ketoprofen—Oedema—Ritonavir—acquired immunodeficiency syndrome	7.57e-05	0.000689	CcSEcCtD
Ketoprofen—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.55e-05	0.000687	CcSEcCtD
Ketoprofen—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.53e-05	0.000685	CcSEcCtD
Ketoprofen—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.51e-05	0.000683	CcSEcCtD
Ketoprofen—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.46e-05	0.000679	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.46e-05	0.000679	CcSEcCtD
Ketoprofen—Shock—Ritonavir—acquired immunodeficiency syndrome	7.45e-05	0.000678	CcSEcCtD
Ketoprofen—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.44e-05	0.000677	CcSEcCtD
Ketoprofen—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	7.43e-05	0.000676	CcSEcCtD
Ketoprofen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.43e-05	0.000676	CcSEcCtD
Ketoprofen—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.41e-05	0.000674	CcSEcCtD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	7.41e-05	0.00181	CbGpPWpGaD
Ketoprofen—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.41e-05	0.000674	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.4e-05	0.000674	CcSEcCtD
Ketoprofen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.4e-05	0.000674	CcSEcCtD
Ketoprofen—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.39e-05	0.000672	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.39e-05	0.000672	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.39e-05	0.00181	CbGpPWpGaD
Ketoprofen—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000671	CcSEcCtD
Ketoprofen—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.38e-05	0.000671	CcSEcCtD
Ketoprofen—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.38e-05	0.000671	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	7.38e-05	0.0018	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.36e-05	0.0018	CbGpPWpGaD
Ketoprofen—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.35e-05	0.000669	CcSEcCtD
Ketoprofen—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.35e-05	0.000668	CcSEcCtD
Ketoprofen—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000666	CcSEcCtD
Ketoprofen—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.32e-05	0.000666	CcSEcCtD
Ketoprofen—Rash—Nevirapine—acquired immunodeficiency syndrome	7.32e-05	0.000666	CcSEcCtD
Ketoprofen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.31e-05	0.000665	CcSEcCtD
Ketoprofen—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.3e-05	0.000664	CcSEcCtD
Ketoprofen—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.3e-05	0.000664	CcSEcCtD
Ketoprofen—Oedema—Saquinavir—acquired immunodeficiency syndrome	7.29e-05	0.000663	CcSEcCtD
Ketoprofen—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.28e-05	0.000662	CcSEcCtD
Ketoprofen—Headache—Nevirapine—acquired immunodeficiency syndrome	7.27e-05	0.000661	CcSEcCtD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.25e-05	0.00177	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	7.25e-05	0.00177	CbGpPWpGaD
Ketoprofen—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.25e-05	0.00066	CcSEcCtD
Ketoprofen—Infection—Saquinavir—acquired immunodeficiency syndrome	7.24e-05	0.000659	CcSEcCtD
Ketoprofen—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.000657	CcSEcCtD
Ketoprofen—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000657	CcSEcCtD
Ketoprofen—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.21e-05	0.000656	CcSEcCtD
Ketoprofen—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.19e-05	0.000655	CcSEcCtD
Ketoprofen—Shock—Saquinavir—acquired immunodeficiency syndrome	7.17e-05	0.000652	CcSEcCtD
Ketoprofen—Discomfort—Lamivudine—acquired immunodeficiency syndrome	7.16e-05	0.000652	CcSEcCtD
Ketoprofen—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.16e-05	0.000651	CcSEcCtD
Ketoprofen—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.14e-05	0.00065	CcSEcCtD
Ketoprofen—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.13e-05	0.000649	CcSEcCtD
Ketoprofen—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.12e-05	0.000648	CcSEcCtD
Ketoprofen—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.12e-05	0.000647	CcSEcCtD
Ketoprofen—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	7.09e-05	0.000645	CcSEcCtD
Ketoprofen—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.09e-05	0.000645	CcSEcCtD
Ketoprofen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.08e-05	0.000644	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.07e-05	0.000643	CcSEcCtD
Ketoprofen—Rash—Stavudine—acquired immunodeficiency syndrome	7.06e-05	0.000643	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.06e-05	0.00173	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.06e-05	0.00173	CbGpPWpGaD
Ketoprofen—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.06e-05	0.000642	CcSEcCtD
Ketoprofen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.06e-05	0.000642	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	7.05e-05	0.00172	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.05e-05	0.000641	CcSEcCtD
Ketoprofen—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000641	CcSEcCtD
Ketoprofen—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.04e-05	0.00064	CcSEcCtD
Ketoprofen—Headache—Stavudine—acquired immunodeficiency syndrome	7.02e-05	0.000639	CcSEcCtD
Ketoprofen—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.02e-05	0.000638	CcSEcCtD
Ketoprofen—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.01e-05	0.000638	CcSEcCtD
Ketoprofen—Constipation—Delavirdine—acquired immunodeficiency syndrome	7e-05	0.000637	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7e-05	0.000637	CcSEcCtD
Ketoprofen—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.99e-05	0.000636	CcSEcCtD
Ketoprofen—Rash—Abacavir—acquired immunodeficiency syndrome	6.96e-05	0.000633	CcSEcCtD
Ketoprofen—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	6.96e-05	0.0017	CbGpPWpGaD
Ketoprofen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.95e-05	0.000633	CcSEcCtD
Ketoprofen—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.95e-05	0.000632	CcSEcCtD
Ketoprofen—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.95e-05	0.000632	CcSEcCtD
Ketoprofen—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000632	CcSEcCtD
Ketoprofen—CXCL8—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	6.94e-05	0.0017	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.92e-05	0.00169	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.92e-05	0.00169	CbGpPWpGaD
Ketoprofen—Headache—Abacavir—acquired immunodeficiency syndrome	6.91e-05	0.000629	CcSEcCtD
Ketoprofen—Infection—Lamivudine—acquired immunodeficiency syndrome	6.91e-05	0.000628	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.9e-05	0.000628	CcSEcCtD
Ketoprofen—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.89e-05	0.000627	CcSEcCtD
Ketoprofen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.89e-05	0.000627	CcSEcCtD
Ketoprofen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.85e-05	0.000623	CcSEcCtD
Ketoprofen—Shock—Lamivudine—acquired immunodeficiency syndrome	6.84e-05	0.000622	CcSEcCtD
Ketoprofen—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000619	CcSEcCtD
Ketoprofen—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.8e-05	0.000618	CcSEcCtD
Ketoprofen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.8e-05	0.000618	CcSEcCtD
Ketoprofen—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.76e-05	0.000615	CcSEcCtD
Ketoprofen—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.75e-05	0.000614	CcSEcCtD
Ketoprofen—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.75e-05	0.000614	CcSEcCtD
Ketoprofen—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.73e-05	0.000612	CcSEcCtD
Ketoprofen—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000611	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.69e-05	0.000609	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.68e-05	0.00163	CbGpPWpGaD
Ketoprofen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.67e-05	0.000607	CcSEcCtD
Ketoprofen—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.67e-05	0.000607	CcSEcCtD
Ketoprofen—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.66e-05	0.000606	CcSEcCtD
Ketoprofen—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.66e-05	0.000606	CcSEcCtD
Ketoprofen—Nausea—Stavudine—acquired immunodeficiency syndrome	6.65e-05	0.000605	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.64e-05	0.000604	CcSEcCtD
Ketoprofen—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.000603	CcSEcCtD
Ketoprofen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.0006	CcSEcCtD
Ketoprofen—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	6.58e-05	0.00161	CbGpPWpGaD
Ketoprofen—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.58e-05	0.000599	CcSEcCtD
Ketoprofen—Nausea—Abacavir—acquired immunodeficiency syndrome	6.56e-05	0.000596	CcSEcCtD
Ketoprofen—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.54e-05	0.000595	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.54e-05	0.000595	CcSEcCtD
Ketoprofen—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.53e-05	0.000594	CcSEcCtD
Ketoprofen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.5e-05	0.000592	CcSEcCtD
Ketoprofen—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.5e-05	0.000591	CcSEcCtD
Ketoprofen—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000591	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.5e-05	0.00159	CbGpPWpGaD
Ketoprofen—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.48e-05	0.000589	CcSEcCtD
Ketoprofen—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.47e-05	0.000589	CcSEcCtD
Ketoprofen—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.47e-05	0.000589	CcSEcCtD
Ketoprofen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.44e-05	0.000586	CcSEcCtD
Ketoprofen—CXCL8—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	6.41e-05	0.00157	CbGpPWpGaD
Ketoprofen—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000584	CcSEcCtD
Ketoprofen—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.41e-05	0.000583	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.39e-05	0.00156	CbGpPWpGaD
Ketoprofen—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.33e-05	0.000576	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.33e-05	0.000576	CcSEcCtD
Ketoprofen—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.3e-05	0.000574	CcSEcCtD
Ketoprofen—CXCL8—Allograft Rejection—TNF—acquired immunodeficiency syndrome	6.29e-05	0.00154	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.29e-05	0.000572	CcSEcCtD
Ketoprofen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.29e-05	0.000572	CcSEcCtD
Ketoprofen—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.28e-05	0.000572	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.28e-05	0.00154	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.28e-05	0.00154	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	6.27e-05	0.00153	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	6.25e-05	0.00153	CbGpPWpGaD
Ketoprofen—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.24e-05	0.000568	CcSEcCtD
Ketoprofen—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.24e-05	0.000568	CcSEcCtD
Ketoprofen—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.23e-05	0.000567	CcSEcCtD
Ketoprofen—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000564	CcSEcCtD
Ketoprofen—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.2e-05	0.000564	CcSEcCtD
Ketoprofen—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.19e-05	0.000563	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.19e-05	0.000563	CcSEcCtD
Ketoprofen—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.000562	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	6.14e-05	0.0015	CbGpPWpGaD
Ketoprofen—Rash—Zidovudine—acquired immunodeficiency syndrome	6.14e-05	0.000559	CcSEcCtD
Ketoprofen—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.14e-05	0.000559	CcSEcCtD
Ketoprofen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.13e-05	0.000558	CcSEcCtD
Ketoprofen—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000557	CcSEcCtD
Ketoprofen—Headache—Zidovudine—acquired immunodeficiency syndrome	6.1e-05	0.000555	CcSEcCtD
Ketoprofen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.05e-05	0.000551	CcSEcCtD
Ketoprofen—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.04e-05	0.00055	CcSEcCtD
Ketoprofen—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.03e-05	0.000549	CcSEcCtD
Ketoprofen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.01e-05	0.000547	CcSEcCtD
Ketoprofen—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6e-05	0.000546	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6e-05	0.000546	CcSEcCtD
Ketoprofen—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.99e-05	0.000545	CcSEcCtD
Ketoprofen—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.99e-05	0.000545	CcSEcCtD
Ketoprofen—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.000544	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.96e-05	0.000542	CcSEcCtD
Ketoprofen—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.94e-05	0.000541	CcSEcCtD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.91e-05	0.00144	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	5.87e-05	0.00144	CbGpPWpGaD
Ketoprofen—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.87e-05	0.000534	CcSEcCtD
Ketoprofen—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.85e-05	0.000533	CcSEcCtD
Ketoprofen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.79e-05	0.000527	CcSEcCtD
Ketoprofen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.79e-05	0.000527	CcSEcCtD
Ketoprofen—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.78e-05	0.000526	CcSEcCtD
Ketoprofen—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.76e-05	0.000524	CcSEcCtD
Ketoprofen—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.76e-05	0.000524	CcSEcCtD
Ketoprofen—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.73e-05	0.000521	CcSEcCtD
Ketoprofen—Rash—Indinavir—acquired immunodeficiency syndrome	5.71e-05	0.000519	CcSEcCtD
Ketoprofen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.7e-05	0.000519	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.68e-05	0.000517	CcSEcCtD
Ketoprofen—Headache—Indinavir—acquired immunodeficiency syndrome	5.67e-05	0.000516	CcSEcCtD
Ketoprofen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.66e-05	0.000515	CcSEcCtD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	5.62e-05	0.00138	CbGpPWpGaD
Ketoprofen—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.6e-05	0.00051	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	5.59e-05	0.00137	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.58e-05	0.000507	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.52e-05	0.00135	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.52e-05	0.00135	CbGpPWpGaD
Ketoprofen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.52e-05	0.000502	CcSEcCtD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.52e-05	0.00135	CbGpPWpGaD
Ketoprofen—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.0005	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	5.46e-05	0.00133	CbGpPWpGaD
Ketoprofen—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.44e-05	0.000495	CcSEcCtD
Ketoprofen—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.43e-05	0.000494	CcSEcCtD
Ketoprofen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.41e-05	0.000493	CcSEcCtD
Ketoprofen—CXCL8—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.4e-05	0.00132	CbGpPWpGaD
Ketoprofen—Rash—Efavirenz—acquired immunodeficiency syndrome	5.39e-05	0.000491	CcSEcCtD
Ketoprofen—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	5.39e-05	0.00132	CbGpPWpGaD
Ketoprofen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.39e-05	0.00049	CcSEcCtD
Ketoprofen—Nausea—Indinavir—acquired immunodeficiency syndrome	5.38e-05	0.000489	CcSEcCtD
Ketoprofen—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000488	CcSEcCtD
Ketoprofen—Headache—Efavirenz—acquired immunodeficiency syndrome	5.36e-05	0.000488	CcSEcCtD
Ketoprofen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.36e-05	0.000487	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.26e-05	0.00129	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.26e-05	0.00129	CbGpPWpGaD
Ketoprofen—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.000476	CcSEcCtD
Ketoprofen—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000474	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.18e-05	0.00127	CbGpPWpGaD
Ketoprofen—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.18e-05	0.000471	CcSEcCtD
Ketoprofen—Rash—Delavirdine—acquired immunodeficiency syndrome	5.16e-05	0.00047	CcSEcCtD
Ketoprofen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.16e-05	0.000469	CcSEcCtD
Ketoprofen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.16e-05	0.000469	CcSEcCtD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	5.13e-05	0.00125	CbGpPWpGaD
Ketoprofen—Headache—Delavirdine—acquired immunodeficiency syndrome	5.13e-05	0.000467	CcSEcCtD
Ketoprofen—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.000466	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	5.11e-05	0.00125	CbGpPWpGaD
Ketoprofen—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.08e-05	0.000462	CcSEcCtD
Ketoprofen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.01e-05	0.000455	CcSEcCtD
Ketoprofen—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.000454	CcSEcCtD
Ketoprofen—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.99e-05	0.000454	CcSEcCtD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	4.97e-05	0.00122	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	4.93e-05	0.00121	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	4.92e-05	0.0012	CbGpPWpGaD
Ketoprofen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.000447	CcSEcCtD
Ketoprofen—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	4.89e-05	0.0012	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	4.88e-05	0.00119	CbGpPWpGaD
Ketoprofen—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.86e-05	0.000442	CcSEcCtD
Ketoprofen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.82e-05	0.000438	CcSEcCtD
Ketoprofen—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.000438	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.78e-05	0.00117	CbGpPWpGaD
Ketoprofen—Rash—Ritonavir—acquired immunodeficiency syndrome	4.77e-05	0.000434	CcSEcCtD
Ketoprofen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.77e-05	0.000434	CcSEcCtD
Ketoprofen—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.76e-05	0.000433	CcSEcCtD
Ketoprofen—Headache—Ritonavir—acquired immunodeficiency syndrome	4.74e-05	0.000431	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.74e-05	0.00116	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.71e-05	0.00115	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.69e-05	0.00115	CbGpPWpGaD
Ketoprofen—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000421	CcSEcCtD
Ketoprofen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.6e-05	0.000418	CcSEcCtD
Ketoprofen—Rash—Saquinavir—acquired immunodeficiency syndrome	4.59e-05	0.000418	CcSEcCtD
Ketoprofen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.59e-05	0.000418	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	4.57e-05	0.00112	CbGpPWpGaD
Ketoprofen—Headache—Saquinavir—acquired immunodeficiency syndrome	4.56e-05	0.000415	CcSEcCtD
Ketoprofen—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.5e-05	0.000409	CcSEcCtD
Ketoprofen—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000402	CcSEcCtD
Ketoprofen—SLC22A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.4e-05	0.00108	CbGpPWpGaD
Ketoprofen—Rash—Lamivudine—acquired immunodeficiency syndrome	4.38e-05	0.000399	CcSEcCtD
Ketoprofen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.38e-05	0.000398	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.36e-05	0.00107	CbGpPWpGaD
Ketoprofen—Headache—Lamivudine—acquired immunodeficiency syndrome	4.35e-05	0.000396	CcSEcCtD
Ketoprofen—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.33e-05	0.000394	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.3e-05	0.00105	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	4.28e-05	0.00105	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	4.25e-05	0.00104	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.2e-05	0.00103	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.14e-05	0.00101	CbGpPWpGaD
Ketoprofen—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.13e-05	0.000376	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	4.07e-05	0.000995	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	4.05e-05	0.000989	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	4.05e-05	0.000989	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	4e-05	0.000979	CbGpPWpGaD
Ketoprofen—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.99e-05	0.000976	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	3.98e-05	0.000973	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	3.98e-05	0.000972	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.95e-05	0.000965	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	3.92e-05	0.000958	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.91e-05	0.000955	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.82e-05	0.000933	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.79e-05	0.000928	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.79e-05	0.000926	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.71e-05	0.000907	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.71e-05	0.000907	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IFNA1—acquired immunodeficiency syndrome	3.7e-05	0.000906	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.68e-05	0.000901	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	3.66e-05	0.000896	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.65e-05	0.000893	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	3.54e-05	0.000865	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.46e-05	0.000846	CbGpPWpGaD
Ketoprofen—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.36e-05	0.000821	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.33e-05	0.000815	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.32e-05	0.000812	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	3.23e-05	0.00079	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.19e-05	0.000779	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.19e-05	0.000779	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	3.19e-05	0.000779	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	3.17e-05	0.000774	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.16e-05	0.000773	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.12e-05	0.000763	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.12e-05	0.000763	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.11e-05	0.000759	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	3.09e-05	0.000757	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	3.09e-05	0.000756	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.01e-05	0.000737	CbGpPWpGaD
Ketoprofen—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.98e-05	0.000729	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.97e-05	0.000727	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.95e-05	0.000721	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.9e-05	0.000709	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.88e-05	0.000705	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.83e-05	0.000693	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.83e-05	0.000693	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.82e-05	0.00069	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.8e-05	0.000685	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.00068	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	2.75e-05	0.000671	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.74e-05	0.00067	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.63e-05	0.000643	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	2.58e-05	0.00063	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.57e-05	0.000629	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—IL6—acquired immunodeficiency syndrome	2.56e-05	0.000626	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	2.55e-05	0.000625	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	2.54e-05	0.000622	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.54e-05	0.000622	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.53e-05	0.000618	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.49e-05	0.000608	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	2.46e-05	0.000601	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.37e-05	0.000581	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	2.35e-05	0.000573	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.34e-05	0.000572	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.24e-05	0.000547	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.16e-05	0.000527	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.14e-05	0.000523	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.12e-05	0.000519	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.09e-05	0.000511	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.08e-05	0.000508	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.05e-05	0.0005	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.04e-05	0.000499	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.03e-05	0.000496	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	2e-05	0.000489	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2e-05	0.000489	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	1.99e-05	0.000488	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.99e-05	0.000486	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.97e-05	0.000482	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.94e-05	0.000475	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	1.93e-05	0.000473	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ALB—acquired immunodeficiency syndrome	1.89e-05	0.000462	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.78e-05	0.000435	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.71e-05	0.000417	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	1.7e-05	0.000416	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.69e-05	0.000413	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.68e-05	0.00041	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.67e-05	0.000409	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.67e-05	0.000409	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.65e-05	0.000404	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.64e-05	0.0004	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.63e-05	0.000398	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000395	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.59e-05	0.000389	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IL2—acquired immunodeficiency syndrome	1.53e-05	0.000375	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.51e-05	0.00037	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000359	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.46e-05	0.000357	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.42e-05	0.000348	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.38e-05	0.000338	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.36e-05	0.000333	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000329	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000321	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.27e-05	0.000311	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000307	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000302	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.21e-05	0.000296	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.15e-05	0.000281	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000274	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000256	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.62e-06	0.000235	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.64e-06	0.000211	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.83e-06	0.000191	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	7.18e-06	0.000176	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	7.09e-06	0.000173	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	6.93e-06	0.000169	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.63e-06	0.000162	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.6e-06	0.000161	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.37e-06	0.000156	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	5.4e-06	0.000132	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	4.51e-06	0.00011	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	4.28e-06	0.000105	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.9e-06	9.53e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	3.49e-06	8.52e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.84e-06	6.94e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	2.44e-06	5.96e-05	CbGpPWpGaD
